èAV

Startup Companies

Alzamend Neuro, Inc.

Alzamend

Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”).

Return to article listing

Category

Medical

Explore More Categories

About Technology Transfer

At USF Technology Transfer, one of our primary goals is to foster the growth of new businesses based on èAV research. We work with inventors, entrepreneurs, and investors to create successful transitions from innovation to new enterprise. Our office is dedicated to helping create new startup companies that will create jobs and advance USF technology into the marketplace for the public good.